|
|
||||||||
1 Departments of Pediatrics, Ophthalmology and Pharmacology, Research Center, Hôpital Sainte-Justine, Montreal, Quebec H3T 1C5; Departments of 2 Pharmacology and Therapeutics and 3 Ophthalmology, McGill University, Montreal, Quebec, Canada H3G 1Y6; and 4 Departments of Pharmacology and Medicine, Vanderbilt University, Nashville, Tennessee 37232-6602
Microvascular degeneration is an
important event in oxygen-induced retinopathy (OIR), a model of
retinopathy of prematurity. Because oxidant stress abundantly
generates thromboxane A2 (TxA2), we tested
whether TxA2 plays a role in retinal vasoobliteration of
OIR and contributes to such vascular degeneration by direct endothelial
cytotoxicity. Hyperoxia-induced retinal vasoobliteration in rat pups
(80% O2 exposure from postnatal days 5-14)
was associated with increased TxB2 generation and was
significantly prevented by TxA2 synthase inhibitor
CGS-12970 (10 mg · kg
1 · day
1) or
TxA2-receptor antagonist CGS-22652 (10 mg · kg
1 · day
1).
TxA2 mimetics U-46619 (EC50 50 nM) and I-BOP
(EC50 5 nM) caused a time- and concentration-dependent cell
death of neuroretinovascular endothelial cells from rats as well as
newborn pigs but not of smooth muscle and astroglial cells; other
prostanoids did not cause cell death. The peroxidation product
8-iso-PGF2, which is generated in OIR, stimulated
TxA2 formation by endothelial cells and triggered cell
death; these effects were markedly diminished by CGS-12970.
TxA2-dependent neuroretinovascular endothelial cell death
was mostly by necrosis and to a lesser extent by apoptosis. The
data identify an important role for TxA2 in
vasoobliteration of OIR and unveil a so far unknown function for
TxA2 in directly triggering neuroretinal microvascular
endothelial cell death. These effects of TxA2 might
participate in other ischemic neurovascular injuries.
endothelium; retina; necrosis; apoptosis; peroxidation
This article has been cited by other articles:
![]() |
A. Dorfman, O. Dembinska, S. Chemtob, and P. Lachapelle Early Manifestations of Postnatal Hyperoxia on the Retinal Structure and Function of the Neonatal Rat Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brault, F. Gobeil Jr., A. Fortier, J.-C. Honore, J.-S. Joyal, P. S. Sapieha, A. Kooli, E. Martin, P. Hardy, A. Ribeiro-da-Silva, et al. Lysophosphatidic acid induces endothelial cell death by modulating the redox environment Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1174 - R1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Quiniou, F. Sennlaub, M. H. Beauchamp, D. Checchin, I. Lahaie, S. Brault, F. Gobeil Jr., M. Sirinyan, A. Kooli, P. Hardy, et al. Dominant Role for Calpain in Thromboxane-Induced Neuromicrovascular Endothelial Cytotoxicity J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 618 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. MONTUSCHI, P. J. BARNES, and L. J. ROBERTS II Isoprostanes: markers and mediators of oxidative stress FASEB J, December 1, 2004; 18(15): 1791 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brault, A. K. Martinez-Bermudez, A. M. Marrache, F. Gobeil Jr, X. Hou, M. Beauchamp, C. Quiniou, G. Almazan, C. Lachance, J. Roberts II, et al. Selective Neuromicrovascular Endothelial Cell Death by 8-Iso-Prostaglandin F2{alpha}: Possible Role in Ischemic Brain Injury Stroke, March 1, 2003; 34(3): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Beauchamp, A. M. Marrache, X. Hou, F. Gobeil Jr, S. G. Bernier, P. Lachapelle, D. Abran, C. Quiniou, S. Brault, K. G. Peri, et al. Platelet-Activating Factor in Vasoobliteration of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3327 - 3337. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Checchin, X. Hou, P. Hardy, D. Abran, T. Najarian, M. H. Beauchamp, S. G. Bernier, F. Gobeil Jr, C. Quiniou, D. R. Varma, et al. PGE2-Mediated eNOS Induction in Prolonged Hypercapnia Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1558 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hatae, M. Wada, C. Yokoyama, M. Shimonishi, and T. Tanabe Prostacyclin-dependent Apoptosis Mediated by PPARdelta J. Biol. Chem., November 30, 2001; 276(49): 46260 - 46267. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al. Prostanoid receptors: ontogeny and implications in vascular physiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al. 2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |